Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Athira Pharma, Inc. | President and CEO, Director | Restricted Stock Units | 325K | $184K | $0.57 | Oct 3, 2024 | Direct |
Athira Pharma, Inc. | President and CEO, Director | Common Stock | 159K | $90.2K | $0.57 | Sep 5, 2024 | Direct |
Athira Pharma, Inc. | President and CEO, Director | Common Stock | 6.56K | $3.71K | $0.57 | Sep 3, 2024 | By Irrevocable Trust of OSL |
Athira Pharma, Inc. | President and CEO, Director | Common Stock | 6.56K | $3.71K | $0.57 | Sep 3, 2024 | By Irrevocable Trust of SWL |
Athira Pharma, Inc. | President and CEO, Director | Common Stock | 6.56K | $3.71K | $0.57 | Sep 3, 2024 | By Irrevocable Trust of WGL |
Athira Pharma, Inc. | President and CEO, Director | Stock Option (Right to Buy) | 325K | Oct 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATHA | Athira Pharma, Inc. | Oct 3, 2024 | 1 | $0 | 4/A | Oct 3, 2024 | President and CEO, Director |
ATHA | Athira Pharma, Inc. | Sep 3, 2024 | 2 | -$2.85K | 4 | Sep 5, 2024 | President and CEO, Director |
ATHA | Athira Pharma, Inc. | Feb 15, 2024 | 1 | $0 | 4 | Feb 16, 2024 | CEO, Director |
ATHA | Athira Pharma, Inc. | Jan 4, 2024 | 2 | -$14K | 4/A | Feb 16, 2024 | CEO, Director |
ATHA | Athira Pharma, Inc. | Jan 4, 2024 | 2 | -$14K | 4 | Jan 8, 2024 | Chief Executive Officer, Director |
ATHA | Athira Pharma, Inc. | Jan 27, 2023 | 2 | $1.81K | 4 | Jan 31, 2023 | Chief Executive Officer, Director |
ATHA | Athira Pharma, Inc. | Jun 22, 2022 | 3 | -$16.1K | 4 | Jun 24, 2022 | Chief Executive Officer, Director |
ATHA | Athira Pharma, Inc. | Jan 27, 2022 | 2 | $11.1K | 4 | Jan 31, 2022 | Chief Executive Officer, Director |
ATHA | Athira Pharma, Inc. | Aug 17, 2021 | 3 | $80.6K | 4 | Aug 19, 2021 | Chief Operating Officer |